beLAB2122 provides drug discovery resources and expertise, thereby significantly reducing timelines and ensuring a greater success rate for emerging therapeutic concepts to reach preclinical and clinical proof-of-concept. We catalyse innovation to create sustainable companies.
Accelerating drug discovery to bring science to patients faster
Building BRIDGES from academia to start-ups
From scouting promising science to propelling it through drug discovery infrastructure and expertise, beLAB2122 drives the process with the goal of transforming discoveries into potential medicines and viable start-up companies.